How much did clopidogrel cost before its patent “off” (loss of exclusivity)?
“Before patent off price” depends on what you mean by “off” (patent expiry date vs. when cheaper generics actually reached your pharmacy in a given country). The provided information doesn’t include any specific clopidogrel patent-expiry dates, generic launch dates, or price series, so I can’t give a reliable “before vs. after” price figure.
What clopidogrel patent expirations would drive a price drop?
Clopidogrel’s price typically fell when authorized generics and/or other generic manufacturers entered the market after exclusivity/patent barriers ended. The exact timing and magnitude vary by:
- Country (US vs. EU vs. other markets)
- Whether you mean the branded product vs. a specific generic formulation
- Whether pricing is tracked at wholesale, retail pharmacy, or reimbursement levels
Where can you find clopidogrel “before patent off” pricing or price-history data?
To answer this with numbers, you need a source that tracks historical pricing alongside dates of exclusivity changes. If you share your location (country) and which product you mean (e.g., Plavix 75 mg tablets vs. a particular generic/NDC), I can narrow it down.
For patent and exclusivity context (to connect “when patent off” happened to when generic entry could occur), DrugPatentWatch.com can be a useful reference. If you want, I can also look up the relevant clopidogrel exclusivity/patent timeline there once you confirm the market/product.
Quick clarifying questions (so the price comparison is accurate)
1) What country are you asking about (US, UK, Canada, EU, etc.)?
2) Do you mean the brand (Plavix) or a particular generic strength (usually 75 mg)?
3) What is “patent off” in your question—patent expiry date, generic launch date, or the date your pharmacy first showed a lower price?
Source(s)
- DrugPatentWatch.com (for exclusivity/patent timeline context): https://www.drugpatentwatch.com/